Medicinova (MNOV) Operating Expenses (2010 - 2025)

Medicinova (MNOV) has 16 years of Operating Expenses data on file, last reported at $3.2 million in Q4 2025.

• On a quarterly basis, Operating Expenses rose 1.9% year-over-year to $3.2 million in Q4 2025; TTM through Dec 2025 was $13.7 million, a 8.03% increase from a year earlier, with the FY2025 full-year figure at $13.7 million, up 8.03% from the prior year.
• Operating Expenses for Q4 2025 stood at $3.2 million, down from $3.5 million in the prior quarter.
• Over the last five years, Operating Expenses for MNOV reached as high as $4.3 million in Q2 2021 and fell as low as $2.1 million in Q4 2021.
• Historically, Operating Expenses has averaged $3.3 million across 5 years, with a median of $3.3 million in 2023.
• Across the five-year window, Operating Expenses plunged 44.92% in 2023 and surged 54.14% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $2.1 million in 2021, then soared by 53.66% to $3.2 million in 2022, then decreased by 22.94% to $2.5 million in 2023, then grew by 27.85% to $3.2 million in 2024, then rose by 1.9% to $3.2 million in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were $3.2 million in Q4 2025, $3.5 million in Q3 2025, and $3.7 million in Q2 2025.